Structures by: Stefinovic M.
Total: 4
(2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol
C21H25ClO5S
Acta Crystallographica Section C (2017) 73, 9
a=5.3945(4)Å b=9.1577(5)Å c=43.475(4)Å
α=90° β=90° γ=90°
(2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol monohydrate
C21H25ClO5S,H2O
Acta Crystallographica Section C (2017) 73, 9
a=4.4659(3)Å b=9.8994(8)Å c=48.073(5)Å
α=90° β=90° γ=90°
Naloxegol hydrogen oxalate
C34H54NO11,C2HO4
Acta Crystallographica Section E (2018) 74, 4 474-477
a=10.35810(10)Å b=13.40390(10)Å c=26.1689(2)Å
α=90° β=90° γ=90°
Idelalisib t-BuOH monosolvate dihydrate
C22H18FN7O,C4H10O,2(H2O)
Acta Crystallographica Section E (2019) 75, 3 414-417
a=21.3758(6)Å b=9.2781(3)Å c=13.9722(5)Å
α=90° β=102.654(3)° γ=90°